|DB00233||Aminosalicylic Acid||For the treatment of tuberculosis|
|DB00626||Bacitracin||For the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. Also used in ointment form for topical treatment of a variety of localized skin and eye infections, as well as for the prevention of wound infections. Used against gram positive bacteria. Bacitracin is also used as an inhibitor of proteases and other enzymes.
However, specific activity of bactracin's inhibition of protein disulfide isomerase has been called into question. |
|DB00807||Proparacaine||Used as a local (ophthalmic) anesthetic.|
|DB00861||Diflunisal||For symptomatic treatment of mild to moderate pain accompanied by inflammation (e.g. musculoskeletal trauma, post-dental extraction, post-episiotomy), osteoarthritis, and rheumatoid arthritis.|
|DB00936||Salicylic acid||Key additive in many skin-care products for the treatment of acne, psoriasis, callouses, corns, keratosis pilaris and warts.|
|DB00945||Acetylsalicylic acid||**Pain, fever, and inflammation**
Acetylsalicylic acid (ASA), in the tablet form (non-extended release), is indicated to relieve pain, fever, and inflammation associated with many conditions, including the flu, the common cold, neck and back pain, dysmenorrhea, headache, tooth pain, sprains, fractures, myositis, neuralgia, synovitis, arthritis, bursitis, burns, and various injuries. It is also used for symptomatic pain relief after surgical and dental procedures [FDA label].
The _extra strength_ formulation of acetylsalicylic acid is also indicated for the management migraine pain with photophobia (sensitivity to light) and phonophobia (sensitivity to sound), which are both frequently associated with migraines [FDA label].
ASA is also indicated for various other purposes, due to its ability to inhibit platelet aggregation. These include:
Reducing the risk of cardiovascular death in suspected cases of myocardial infarction (MI) [FDA label].
Reducing the risk of a first non-fatal myocardial infarction in patients, and for reducing the risk of morbidity and mortality in cases of unstable angina and in those who have had a prior myocardial infarction [FDA label].
For reducing the risk of transient ischemic attacks (TIA) and to prevent atherothrombotic cerebral infarction (in conjunction with other treatments) [FDA label].
For the prevention of thromboembolism after hip replacement surgery [FDA label].
For decreasing platelet to platelet adhesion following carotid endarterectomy, aiding in the prevention of transient ischemic attacks (TIA) [FDA label].
Used for patients undergoing hemodialysis with a silicone rubber arteriovenous cannula inserted to prevent thrombosis at the insertion site [FDA Label].
**Important note regarding use in acute clinical situations**
In the setting of acute myocardial infarction, or before percutaneous interventions, the extended release form of acetylsalicylic acid should not be used. Use non-extended release or non-delayed release in scenarios requiring rapid onset of action [Label, F4406].
|DB01014||Balsalazide||For the treatment of mildly to moderately active ulcerative colitis.|
|DB01233||Metoclopramide||For the treatment of gastroesophageal reflux disease (GERD). It is also used in treating nausea and vomiting, and to increase gastric emptying.|
|DB01250||Olsalazine||For the treatment of Inflammatory Bowel Disease and Ulcerative Colitis.|
|DB01294||Bismuth subsalicylate||Used to treat nausea, heartburn, indigestion, upset stomach, diarrhea, and other temporary discomforts of the stomach and gastrointestinal tract.|
|DB01397||Magnesium salicylate||Magnesium salicylate is a common analgesic and non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate muscular pain|
|DB01399||Salsalate||For relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorders.|
|DB01401||Choline magnesium trisalicylate||Choline magnesium trisalicylate is used to reduce pain and inflammation caused by conditions such as arthritis. This medication is also used to treat fever in adults.|
|DB02795||P-Anisic Acid||Not Available|
|DB03644||3-hydroxyanthranilic acid||Not Available|
|DB06251||Dersalazine||Investigated for use/treatment in inflammatory bowel disease.|
|DB06807||Phenyl aminosalicylate||Not Available|
|DB08814||Triflusal||Triflusal is indicated as prophylaxis of thromboembolic disorders.[L1185] It has been registered in Spain and in other countries of Europe, South America and South Korea for the prevention of Stroke and myocardial infarction.[T93]|
|DB09018||Bromopride||Bromopride in indicated in the treatment of nausea and vomiting, including PONV (post-operative nausea and vomiting), gastroesophageal reflux disease (GERD/GORD), as well as endoscopy preparation and radiographic studies of the GI tract. |
|DB09089||Trimebutine||Indicated for symptomatic treatment of irritable bowel syndrome (IBS) and treatment of postoperative paralytic ileus following abdominal surgery. |
|DB09342||Propoxycaine||Propoxycaine is a local anesthetic medication. It was used beginning in the 1950s during dental procedures [L1591]. It has been combined with procaine to accelerate its onset of action and provide longer-lasting anesthetic effect [L1592].
It was produced for use when amide local anesthetics were contraindicated due to allergy or when several amide anesthetics were unsuccessful [L1592].|
|DB09543||Methyl salicylate||Ointments or liniments containing methyl salicylate are applied topically as counter irritant for relief of acute pain associated with lumbago,sciatica and rheumatic conditions. Local analgesics for human and veterinary medicine.|
|DB11062||Octisalate||Ingredient in sunscreens for protection against damage effects of sun light, provides protection from sunburns, aging and skin cancer. |
|DB11064||Homosalate||As ingredient in many sunscreen for protection against sunburn, skin aging and skin cancer. |
|DB11071||Phenyl salicylate||Pain and fever [L2468].|
|DB11079||Trolamine salicylate||Indicated for the temporary relief of aches, and pains of muscles and joints associated with backache, lumbago, strains, bruises, sprains and arthritic or rheumatic pain, pain of tendons and ligaments [L1791].|
|DB11323||Glycol salicylate||This drug is only recommended for topical usages for the relief of muscular and rheumatic pain in human and animals [L2687].|
|DB11324||Nonivamide|| Nonivamide is used as a topical analgesic and is also used as a flavoring ingredient [L2641], [A32884], [L2642]. |
|DB12450||Propyl Gallate||Not Available|
|DB13612||Carbaspirin calcium||Not Available|
|DB13628||Ethyl hydroxybenzoate||Not Available|
|DB13864||Hemoglobin crosfumaril||Not Available|
|DB13909||Bismuth subgallate||The most common medical purpose for which bismuth subgallate is currently and formally indicated for is the use as a non-prescription internal deodorant product for the purpose of deodorizing flatulence and stools [L2309, L2312, A32566].
Additionally, there are also various non-prescription (over the counter) bismuth subgallate based wound healing products as well as ongoing studies into whether or not the substance can be utilized as a legitimate hemostatic agent - usually for soft tissue surgery in otorhinolaryngology and/or dermatologic settings [A32567, A32568, A32569, A32570].
Moreover, in the past bismuth subgallate may have seen some use as a treatment for Helicobacter pylori infection [A32571]. In contrast, contemporary first-line therapies generally involve proton pump inhibitor and antibiotic combination therapies that generally achieve high rates of pathogen eradication, ease of administration, and patient compliance.|
|DB14006||Choline salicylate||The oral gel is indicated for the relief of pain and discomfort of common mouth ulcers, cold sores, denture sore spots, infant teething and mouth ulcers, and sore spots due to orthodontic devices in children [L2135].
|DB14026||Thiosalicylic acid||Not Available|
|DB14176||Benzylparaben||Benzylparaben is used in allergenic testing.|
|DB14177||Propylparaben||Propylparaben is used in allergenic testing.|
|DB02130||Vanillic acid||Not Available|
|DB00244||Mesalazine||Mesalazine is indicated for the induction of remission in patients with active or mild to moderate acute exacerbations of ulcerative colitis and for the maintenance of remission of ulcerative colitis [FDA Label], [L5101]. Prescribing information for mesalazine in the UK also indicates the medication for the maintenance of remission of Crohn's ileo-colitis [L5101].|